鼎稔道學館
📚 學術論文公開狀態:已發布(不等於考據完成)

中醫藥雜誌稿約

📅 2012

中 醫 藥 雜 誌 稿 約 一、投稿: 1、本刊已於 2012 年 8 月榮獲財團法人醫院評鑑暨醫療品質策進會之「教學醫院 評鑑學術性期刊認定」,符合「教學醫院評鑑同儕審查學術性期刊認定標準」。 凡與中醫藥有關之論著,均為本雜誌徵稿之對象,但以未曾刊載或不再刊載於 其他刊物者為限。 2、本雜誌稿件應儘可能以英文繕寫,亦接受中文投稿,須提供英文摘要。 3、稿件請以電子郵件投遞:[email protected]。 二、 論文的種類:原始論文 (Original Articles)、簡要論文 (Notes)、回顧性論文 (Review Articles)、病例報告 (Case Reports)、快訊 (Communication)、會議報告 (Meeting Reports) 與讀者來信 (Letters to the Editor) 等,其中回顧性論文與會議報告得由 主編邀請撰稿。 三、 投稿格式:文稿請以電腦繕打,行距為 2 倍行高,紙張大小為 A4,預留 3 公分 邊界,並提供全文 Microsoft Word ( .doc) 與 PDF 檔。文稿須按以下順序排列︰ 標題、

⬇ Markdown / Obsidian🔗 v20260609

📚 學術摘要使用聲明

本頁面收錄論文摘要係依據台灣《著作權法》第 52 條(為學術研究合理使用) 及第 65 條(合理使用四要素判斷)整理。摘要長度不超過 300 字,並附原始來源連結。

若您是著作權人並希望下架此摘要,請來信 [email protected] 我們將於 7 日內處理。原文閱讀請點擊「來源連結」前往原資料庫。

來源與整理狀態: 收錄狀態:此頁展示站內保存的內容;公開狀態不等同於所有歷史主張都已獲外部證實。

中 醫 藥 雜 誌 稿 約

一、投稿:

1、本刊已於 2012 年 8 月榮獲財團法人醫院評鑑暨醫療品質策進會之「教學醫院 評鑑學術性期刊認定」,符合「教學醫院評鑑同儕審查學術性期刊認定標準」。 凡與中醫藥有關之論著,均為本雜誌徵稿之對象,但以未曾刊載或不再刊載於 其他刊物者為限。

2、本雜誌稿件應儘可能以英文繕寫,亦接受中文投稿,須提供英文摘要。 3、稿件請以電子郵件投遞:[email protected]

二、 論文的種類:原始論文 (Original Articles)、簡要論文 (Notes)、回顧性論文 (Review Articles)、病例報告 (Case Reports)、快訊 (Communication)、會議報告 (Meeting Reports) 與讀者來信 (Letters to the Editor) 等,其中回顧性論文與會議報告得由 主編邀請撰稿。

三、 投稿格式:文稿請以電腦繕打,行距為 2 倍行高,紙張大小為 A4,預留 3 公分 邊界,並提供全文 Microsoft Word (* .doc) 與 PDF 檔。文稿須按以下順序排列︰ 標題、英文摘要、本文 ( 前言、材料與方法,結果與討論 )、誌謝、參考文獻、 表格、圖片、所有圖片說明及中文摘要。 文稿格式的要求如下︰ 1、標題頁 (Title page):標題頁應該包含標題 ( 英文 40 字以內,中文 20 字以內; 英文每一字首大寫 )、所有作者全名、服務機構或實驗室地址、通訊作者之地 址、 電話、傳真號碼及電子郵件信箱及簡題,以上資料均須以中英文完整書寫。 標題不應該包括數字、字首縮略詞、縮寫詞或標點符號。

2、摘要 (Abstract) ︰摘要勿超過 400 字,關鍵字最多 6 個。中文或英文稿件均須

附中英文摘要,非中文或英文稿件則須附英文摘要。

3、本文 (Text):包含前言、材料與方法、結果以及討論等部分。

(1) 原始論文:須依前言、材料與方法、結果、討論分項撰述。 (2) 簡要論文:較簡要的前言、結果與討論合併撰寫且無次標題。 (3) 回顧性論文:為介紹某一領域的綜合性的論文,不必遵循上述論文形式,

但應適當分段。

(4) 病例報告:包含前言、材料與方法 ( 改為病例闡述,包含病歷、症狀、進行 之試驗與任何治療,但勿洩漏病患的身分 )、結果以及討論。此外應附上病 患的簽字同意發表。

(5) 快訊:作者應合併前言、材料與方法、結果與討論撰寫而均無次標題,並

附上該論文為具刊登時效之說明信。

(6) 會議報告:本文之材料與方法與結果改為開會經過,其他格式同上。

4、參考文獻 (References) ︰按照在本文內出現之先後順序在標點符號之前給予上

標數字,並在文末依序列出。範例如下: — 期刊論文 —

  1. Yang HY, Tan JP, Chen CF. Central pharmacological effects of five Chinese

herbs. J. Chin. Med., 40:193-200, 1987.

  1. 韓曉輝、馬志紅、石玉娥、王鑫國、李愛英,富硒靈芝對 D- 半乳糖衰老

模型大鼠的抗衰老作用研究,中藥藥理與臨床,22:42-44,2006。

— 書 —

  1. Emboden W. Narcotic Plants. Studio Vista, London, pp. 57-81, 1972.
  2. 黃維三,針灸科學,正中書局,台北,pp. 606-608,1985。 3.(明)張介賓,景岳全書,台聯國風出版社,台北,pp. 76-78,1970。

— 多著者之書 —

  1. Wang YM, Hu YJ.“Toxicity and Side Effects of Some Chinese Medicinal Herbs,” in Chang HM, Yeung HW, Tso WW, Koo A(eds.), Advances in Chinese Medicinal Materials Research. World Scientific Pub Co Pte Ltd., Singapore, pp. 109-124, 1985.

  2. 楊乾中、張錦川,實務 DBASE & FOXBASE & CLIPPER 程式設計問題

集,耐峰資訊股份有限公司,臺北,1990。

5、同意聲明 (Consent,僅限於病例報告 ):病患應允發表病例報告與不涉隱私的相 關圖像的同意聲明。本刊不接受欠缺同意聲明之病例報告。若病患已身故,須 經病患的至親同意發表。未成年病患須經病患的父母或法定監護人同意。 6、誌謝 (Acknowledgements):致謝對象應以確實有貢獻之個人或機構為限。 7、表格 (Tables) ︰每一表格應分開另紙繕打,說明列於表格下方。 8、圖片 (Figures) ︰說明列於圖下方,圖片必須標明號碼並在本文中註明,並於頁 尾標明作者;附圖及結構式 (ChemDraw) 應以軟體清楚繪製。插圖及照片須標 明比例尺寸,並請提供電子檔。

9、縮寫詞 (Abbreviations) ︰除了已知常用之縮寫詞,所有的縮寫詞在首次提到時 就應解釋清楚。作者應遵循正統命名法,例如 IUPAC-IUB 委員會建議的生物 化學命名法。標題不使用縮寫詞,但簡題可帶進縮寫詞。

10、度量單位 (Units of measure) ︰一律用公制單位 (International System of Units,

SI) 標準符號,請使用阿拉伯數字 ( 英文句首除外 )。

11、如文稿需分項敘述,其符號請依1.、1.1.、1.1.1.、2.、2.1.、2.1.1.…次序採 用; 須加註腳處以指定符號註明之,依次為 a、b、c、d;…等。

四、為使惠稿合乎標準格式,本雜誌編輯委員會保有修改權。 五、 惠稿經本雜誌採用後,由本雜誌免費提供通訊作者所投稿論文之全文PDF檔。 六、惠稿一經刊載,版權即為本雜誌所有,但著者仍可保有專利商標,並在誌謝原出

版者之原則下,保有其使用論著內全部或部分資訊之權利。

Instructions to Authors

  1. Manuscript submission:

(1)The Journal of Chinese Medicine has received the certification of Teaching Hospital Accreditation Scholarly Journal approved by Taiwan Joint Commission on Hospital Accreditation (TJCHA), and conformed to the certification standards of peer-review scholarly journal. This Journal will accept original contributions in traditional Chinese medicine in its broadest sense, such as Chemistry, Pharmacy, Pharmacology, Prescriptionology, and processing of Chinese Materia Medica, Acupuncture and Moxibustion Medicine, Pharmaceutical Botany, etc. Manuscripts are submitted with the understanding that it is not being considered for publication elsewhere, and that it has not been or will not be published elsewhere.

(2)The manuscript should preferably be written in English while Chinese contributions providing

the English abstract are also accepted.

(3)The manuscript should be submitted by e-mail: [email protected].

  1. Categories of signed papers : Original Articles, Notes, Review Articles, Case Reports, Communication, Meeting Reports, and Letters to the Editor etc. Review Articles and Meeting Reports are solicited or invited by the editors.

  2. Manuscript formats : Manuscript submitted by e-mail or on disk should be typed double-spaced on one side of A4 paper, with outer margins of 3 cm in Microsoft Word document format (*.doc) which should be converted to the PDF file. Manuscripts should be arranged in the following order: title, English abstract, text (Introduction, Materials and Methods, Results, and Discussion sections), acknowledgements, references, tables, illustrations, legends for all illustrations, and Chinese abstract. Requirements for Manuscript Format are as follows: (1)Title page : The title page should contain the title (English title limit of 40 words, Chinese title limit of 20 words; every prefix of English one is capitalized), authors’ names (English full names), address of institutional affiliations or laboratories (English full names); mailing address, telephone and fax numbers, and e-mail address of the corresponding author(s), brief running title, key words, and footnotes, all of which should be written completely in English and Chinese. Titles should not include numbers, acronyms, abbreviations or punctuation. (2)Abstract : An abstract does not exceed 400 words followed by a list of no more than 6 key words. All English or Chinese manuscripts should offer Chinese and English abstracts, neither English nor Chinese manuscripts should offer an English abstract.

(3)Text : The text of the manuscript should contain Introduction, Materials and Methods, Results,

and Discussion, Requirements for Text are as follows: ① Original Articles : They should be written in order of the Introduction, Materials and

Methods, Results, and Discussion sections respectively,

② Notes : Combine briefer Introduction, Results and Discussion without subheading. ③ Review Articles : Review Articles which are Comprehensive review papers of some field do not have to follow above-mentioned format, but should be divided into appropriate sections.

④ Case Reports : They should contain Introduction, Materials and Methods (This section should be changed to Case Presentation, including any relevant medical history of the patient, the patient's symptoms and signs, and any tests that were carried out and a description of any treatment without adding any details that could lead to the identification of the patient), Results and Discussion sections. In addition, it should provide a statement to confirm that the patient has given their signature consent for the case report to be published. ⑤ Communication : Authors should combine Introduction, Materials and Methods, Results and Discussion without subheading and offer explanation letter for publication timeliness. ⑥ Meeting Reports : The text of the Materials and Methods, and Results sections should be

changed to the meeting process. Other sections are the same above-mentioned format. (4)References: Number of the references referred to in the text as consecutive, superscript numbers before punctuation marks in the order of their first mention in the text. Complete listing of references should appear at the end of the article, in the same order of citation.

Examples are given as follows: Journal article : Yang HY, Tan JP, Chen CF. Central pharmacological effects of five Chinese herbs. J. Chin. Med., 40:193-200, 1987. Book : Emboden W. Narcotic Plants. Studio Vista, London, pp. 57-81, 1972. Multiauthor book article : Wang YM, Hu YJ. “Toxicity and Side Effects of Some Chinese Medicinal Herbs,” in Chang HM, Yeung HW, Tso WW, Koo A(eds.), Advances in Chinese Medicinal Materials Research. World Scientific Pub Co Pte Ltd., Singapore, pp. 109-124, 1985.

(5) Consent (Case Reports only) : It is a statement that the patient has given their informed consent for the case report and relevant pictures not involving in personal secrets to be published. Manuscripts will not be accepted if a statement of patient consent is not present. If the patient has died, then consent for publication must be sought from the next of kin of the patient. If the patient is minor, then consent must be sought from the parents or legal guardians of the patient.

(6) Acknowledgements : Please acknowledge anyone or institutions who really contributed

towards the study.

(7) Tables : Type each table with a caption on a separate sheet. Table legends should be put under

tables.

(8) Figures : Figures legends should be put under figures and typed on a separate sheet. Figures must be numbered and identified in the text. The name(s) of the author(s) should be marked on the bottom of the page. Line drawings and all structural formulas must be submitted as the original drawings drawn in software (eg, ChemDraw). The illustration and photo must be indicated the size of proportion, and please offer them with the text with the clear soft copy. (9) Abbreviations : All abbreviations must be explained at first mention unless the term is better known as an abbreviation. Authors should follow the recommendations of the IUPAC-IUB Commission on Biochemical Nomenclature. Abbreviations are not to be used in titles, but running titles may carry abbreviations for brevity.

(10) Units of measure : All measurements should be presented in metric units (International System of Units, SI). Please use Arabic numerals (except the beginning of the English sentence).

(11) If the text would be paragraphed, please use “1.、1.1.、1.1.1.、2.、2.1.、2.1.1.……” as symbols in order ; If the text would be added footnotes, please use “a、b、c、d……;……” as symbols in order。

  1. The Editorial Board reserves the right to amend the text of a manuscript to meet editorial standard

formats.

  1. We will send a free PDF copy of the accepted article to the corresponding author.
  2. The copy right of the article will be transferred to the Journal of Chinese Medicine upon its publication. However, the author(s) reserve(s) the following: (a) trademark and patent rights, if any; and (b) the right to use all or part of the information contained in the article in future, non-commercial works of the author(s), provided that acknowledgements are given regarding copyright notice and reference is made to the original publication.

法緣留言(

載入中…

ID: paper:1094630d4d7c · 最後更新:2026/6/9· 版本:20260609 · 版本歷史

其他資料:學術論文(個別著作權)、本派傳承(CC0 1.0)。